SYRE Spyre Therapeutics, Inc.
NEUTRAL
Impact: 3/10
EFFECT
IPO/offering going effective
Final — all horizons settled through T+60d
SYRE ▲ +73.33% at T+60d
NEUTRAL call ✓ call won +73.33% · α vs SPY +64.01% · entry $42.49 → $73.65
Last close $72.00 (close Jun 8) · +69.45% from $42.49 entry
T+1d
-5.70%
call -5.70% · α -4.78%
$40.07
settled 3mo ago
T+5d
-3.34%
call -3.34% · α -2.13%
$41.07
settled 3mo ago
T+20d
+6.90%
call +6.90% · α +14.83%
$45.42
settled 2mo ago
T+60d
+73.33%
call +73.33% · α +64.01%
$73.65
settled 14d ago
Price Chart
Loading chart...
Executive Summary
Spyre Therapeutics' shelf registration (Form S-3) has become effective, allowing the company to issue unspecified securities from time to time. This is a routine capital markets update with no immediate financial impact.
Actionable Insight
Monitor for future prospectus supplements that will disclose actual offering terms, timing, and size. Shelf registrations allow flexibility but create potential dilution overhang.
Key Facts
- Form EFFECT filed for Spyre Therapeutics, Inc. (SYRE)
- Effectiveness date: February 27, 2026
- Underlying registration is Form S-3 (shelf registration)
- No specific offering size, pricing, or securities type disclosed
- Company previously known as Aeglea BioTherapeutics, Inc.
Financial Impact
Not specified
dilutioncapital_structure
Risk Factors
- Future issuance could lead to shareholder dilution
- Market perception of equity overhang may pressure stock price
Market Snapshot
Exchange
Nasdaq
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-000695 |
| Document: 9999999995-26-000695-index.html | 9999999995-26-000695 |
| Document: 9999999995-26-000695.txt | 9999999995-26-000695 |
16 reports for SYRE
83%
Hit rate
best @ T+20▲ +20.80%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
6d ago
|
Insider Cluster
| $78.48 $73.65 | ▼ −6.15% | ▼ −3.56% | $72.00 (−8.26%) |
|
Jun 1, 2026
8d ago
|
8-K
| $69.16 $73.52 | ▲ +6.30% | ▲ +7.00% | $72.00 (+4.11%) |
|
May 29, 2026
11d ago
|
8-K
| $70.54 $69.16 | ▼ −1.96% | ▼ −2.10% | $72.00 (+2.07%) |
|
May 5, 2026
5w ago
|
8-K
| $71.01 $73.00 | ▲ +2.80% | ▲ +1.42% | $72.00 (+1.39%) |
|
May 1, 2026
5w ago
|
Insider Cluster
| $69.42 $69.13 | ▼ −0.42% | ▼ −0.08% | $72.00 (+3.72%) |
|
May 1, 2026
5w ago
|
Insider Cluster
| $69.42 $69.13 | ▼ −0.42% | ▼ −0.08% | $72.00 (+3.72%) |
|
Apr 15, 2026
8w ago
|
Press Release
| $68.99 $69.70 | ▲ +1.03% | ▲ +0.78% | $72.00 (+4.36%) |
|
Apr 13, 2026
8w ago
|
424B5
| $64.01 $68.99 | ▲ +7.78% | ▲ +7.01% | $72.00 (+12.48%) |
|
Apr 13, 2026
8w ago
|
Press Release
| $64.01 $68.99 | ▼ −7.78% | ▼ −7.01% | $72.00 (−12.48%) |
|
Apr 13, 2026
8w ago
|
8-K
| $64.01 $68.99 | ▲ +7.78% | ▲ +7.01% | $72.00 (+12.48%) |
Showing 10 of 16
US Market Status
Market Closed — Opens in 7h 16m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access